Suppr超能文献

钙通道激动剂BAY k 8644可减少嗜酒AA大鼠的乙醇摄入量和偏好。

The calcium channel agonist BAY k 8644 reduces ethanol intake and preference in alcohol-preferring AA rats.

作者信息

de Beun R, Schneider R, Klein A, Lohmann A, Schreiber R, De Vry J

机构信息

Institute of Neurobiology, Köln, Germany.

出版信息

Psychopharmacology (Berl). 1996 Oct;127(4):302-10. doi: 10.1007/s002130050090.

Abstract

Applying a 12-h limited access, two-bottle choice procedure, antialcohol effects of the 1,4-dihydropyridine (DHP) L-type calcium (Ca2+) channel agonist BAY k 8644 were investigated in alcohol-preferring AA rats. In this Wistar line, selectively bred for a high 10% v/v ethanol (EtOH) preference in a free choice situation, effects on EtOH preference and intake, as well as on food and total fluid intake were evaluated for racemic BAY k 8644 (0.1-1 mg/kg IP; 0.25-2 mg/kg PO), its agonistic (-)-enantiomer (0.1-1 mg/kg IP and PO) and its antagonistic (+)-enantiomer (10-50 mg/kg IP and PO). Irrespective of route of application, BAY k 8644 was found to be effective in reducing both EtOH intake and preference (minimal effective dose: 0.5 mg/kg; maximum effect: approximately 60% of baseline levels). The (+)-enantiomer, acting as a low-potency Ca2+ channel antagonist, also reduced EtOH intake and preference, but the effects were not very selective as food intake was also substantially reduced. Moreover, the effects were only obtained at relatively high doses (50 mg/kg). The essential enantiomer involved in the antialcohol effects of BAY k 8644 seems to be the (-)-enantiomer, acting as a strong Ca2+ channel agonist. This latter compound was potent (minimal effective dose: 0.3 mg/kg), very effective in reducing EtOH intake (maximum effect: 29% of baseline level) and preference (26% of baseline) and apparently more selective. Although slightly decreasing over days, effects of (-)-BAY k 8644 on EtOH intake and preference were shown to remain after repeated treatment (10 successive days, 0.3 mg/kg IP). Interestingly, the acute antialcohol effects of (-)-BAY k 8644 (0.3-1 mg/kg IP) could not be antagonized with the DHP L-type Ca2+ channel antagonists nimodipine (0.01-1 mg/kg IP) and (-)-nimodipine (1-30 mg/kg IP). The present results suggest that a mechanism of action other than L-type Ca2+ channel agonism is involved in the antialcohol effects of (+/-)- and (-)-BAY k 8644. Alternatively, it is possible that the previously described antialcohol effects of DHP Ca2+ channel antagonists are not related to antagonistic activity at Ca2+ channels. Finally, it cannot be excluded that a mechanism unrelated to Ca2+ channels is responsible for the antialcohol effects of both DHP Ca2+ channel agonists and antagonists.

摘要

采用12小时限时进入、双瓶选择程序,在嗜酒的AA大鼠中研究了1,4 - 二氢吡啶(DHP)L型钙(Ca2+)通道激动剂BAY k 8644的抗酒精作用。在这个Wistar品系中,通过在自由选择情况下选择性培育,使其对10%(v/v)乙醇(EtOH)具有较高偏好,评估了消旋BAY k 8644(0.1 - 1 mg/kg腹腔注射;0.25 - 2 mg/kg口服)、其激动性(-)-对映体(0.1 - 1 mg/kg腹腔注射和口服)及其拮抗性(+)-对映体(10 - 50 mg/kg腹腔注射和口服)对EtOH偏好和摄入量以及食物和总液体摄入量的影响。无论给药途径如何,发现BAY k 8644均能有效降低EtOH摄入量和偏好(最小有效剂量:0.5 mg/kg;最大效应:约为基线水平的60%)。作为低效Ca2+通道拮抗剂的(+)-对映体也能降低EtOH摄入量和偏好,但效果不太具有选择性,因为食物摄入量也大幅减少。此外,仅在相对高剂量(50 mg/kg)时才获得这些效果。BAY k 8644抗酒精作用中涉及的必需对映体似乎是作为强Ca2+通道激动剂的(-)-对映体。后一种化合物效力较强(最小有效剂量:0.3 mg/kg),在降低EtOH摄入量(最大效应:基线水平的29%)和偏好(基线的26%)方面非常有效,且显然更具选择性。尽管随着时间推移略有下降,但(-)-BAY k 8644对EtOH摄入量和偏好的影响在重复治疗(连续10天,0.3 mg/kg腹腔注射)后仍持续存在。有趣的是,(-)-BAY k 8644(0.3 - 1 mg/kg腹腔注射)的急性抗酒精作用不能被DHP L型Ca2+通道拮抗剂尼莫地平(0.01 - 1 mg/kg腹腔注射)和(-)-尼莫地平(1 - 30 mg/kg腹腔注射)拮抗。目前的结果表明,(±)-和(-)-BAY k 8644的抗酒精作用涉及L型Ca2+通道激动作用以外的作用机制。或者,有可能先前描述的DHP Ca2+通道拮抗剂的抗酒精作用与Ca2+通道的拮抗活性无关。最后,不能排除与Ca2+通道无关的机制导致DHP Ca2+通道激动剂和拮抗剂的抗酒精作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验